Crispr Therapeutics Quote - 0VRQ

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

64.60

Bid

0.00

Ask

0.00

Volume

0.00

0.00 Day's Range 0.00

64.60 52 Week Range 64.60

Market Cap

5.16B

Previous Close

64.60

Open

Last Trade

40.7705

(O)

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

5,473

Shares Outstanding

79,874,000

Dividend Yield

PE Ratio

-33.59

Earnings Per Share (EPS)

-1.92

Revenue

371.21M

Net Profit

-153.61M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.crisprtx.com

Headquarters

Zug, Che

Founded

Crispr Therapeutics Ag is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0VRQ. The last closing price for Crispr Therapeutics was US$64.60. Over the last year, Crispr Therapeutics shares have traded in a share price range of US$ 64.60 to US$ 64.60.

Crispr Therapeutics currently has 79,874,000 shares outstanding. The market capitalization of Crispr Therapeutics is US$5.16 billion. Crispr Therapeutics has a price to earnings ratio (PE ratio) of -33.59.

No news to show yet.

Period	Open	High	Low	Avg. Daily Vol	VWAP
1	64.6	64.6	64.6	4972	64.6	DE
4	64.6	64.6	64.6	5208	64.6	DE
12	64.6	64.6	64.6	5473	64.6	DE
26	64.6	64.6	64.6	4110	64.6	DE
52	64.6	64.6	64.6	4293	64.6	DE
156	64.6	64.6	64.6	2696	64.6	DE
260	64.6	64.6	64.6	1880	64.6	DE

0VRQ - Frequently Asked Questions (FAQ)

What is the current Crispr Therapeutics share price?

The current share price of Crispr Therapeutics is US$ 64.60

How many Crispr Therapeutics shares are in issue?

Crispr Therapeutics has 79,874,000 shares in issue

What is the market cap of Crispr Therapeutics?

The market capitalisation of Crispr Therapeutics is USD 5.16B

What is the 1 year trading range for Crispr Therapeutics share price?

Crispr Therapeutics has traded in the range of US$ 64.60 to US$ 64.60 during the past year

What is the PE ratio of Crispr Therapeutics?

The price to earnings ratio of Crispr Therapeutics is -33.59

What is the cash to sales ratio of Crispr Therapeutics?

The cash to sales ratio of Crispr Therapeutics is 13.9

What is the reporting currency for Crispr Therapeutics?

Crispr Therapeutics reports financial results in USD

What is the latest annual turnover for Crispr Therapeutics?

The latest annual turnover of Crispr Therapeutics is USD 371.21M

What is the latest annual profit for Crispr Therapeutics?

The latest annual profit of Crispr Therapeutics is USD -153.61M

What is the registered address of Crispr Therapeutics?

The registered address for Crispr Therapeutics is BAARERSTRASSE 14, ZUG, 6300

What is the Crispr Therapeutics website address?

The website address for Crispr Therapeutics is www.crisprtx.com

Which industry sector does Crispr Therapeutics operate in?

Crispr Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
0A2IH World Group Ltd	US$ 0.00 (0.00%)	0
0A2DCrh Plc	US$ 0.00 (0.00%)	0
0A2BBanco Bilbao Vizcaya Argentaria Sa	US$ 0.00 (0.00%)	0
0A22Anheuser Busch Inbev Nv	US$ 0.00 (0.00%)	0
0A1UUber Technologies Inc	US$ 68.40 (0.00%)	0
0A2IH World Group Ltd	US$ 0.00 (0.00%)	0
0A2DCrh Plc	US$ 0.00 (0.00%)	0
0A2BBanco Bilbao Vizcaya Argentaria Sa	US$ 0.00 (0.00%)	0
0A22Anheuser Busch Inbev Nv	US$ 0.00 (0.00%)	0
0A1UUber Technologies Inc	US$ 68.40 (0.00%)	0
0A2IH World Group Ltd	US$ 0.00 (0.00%)	0
0A2DCrh Plc	US$ 0.00 (0.00%)	0
0A2BBanco Bilbao Vizcaya Argentaria Sa	US$ 0.00 (0.00%)	0
0A22Anheuser Busch Inbev Nv	US$ 0.00 (0.00%)	0
0A1UUber Technologies Inc	US$ 68.40 (0.00%)	0